Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-10-19
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0307-6938
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
321-7
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:2476267-Animals,
pubmed-meshheading:2476267-Aprotinin,
pubmed-meshheading:2476267-Disease Models, Animal,
pubmed-meshheading:2476267-Fibrinolysin,
pubmed-meshheading:2476267-Humans,
pubmed-meshheading:2476267-Mice,
pubmed-meshheading:2476267-Mice, Inbred BALB C,
pubmed-meshheading:2476267-Pemphigus
|
pubmed:year |
1988
|
pubmed:articleTitle |
Aprotinin inhibition of experimental pemphigus in Balb-c mice following passive transfer of pemphigus foliaceus serum.
|
pubmed:publicationType |
Journal Article
|